Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma.

@article{Rohatiner1994MyeloablativeTW,
  title={Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma.},
  author={Ama Z. S. Rohatiner and Peter W M Johnson and Colin Price and Stephen J. Arnott and J. A. L. Amess and Andrew J. Norton and E. L. Dorey and Kirsten Adams and Jeremy Simon Whelan and Janet M Matthews},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={1994},
  volume={12 6},
  pages={1177-84}
}
PURPOSE To assess myeloablative therapy with autologous bone marrow transplantation (ABMT) in younger patients with follicular lymphoma in the hope of prolonging remission duration and survival. PATIENTS AND METHODS Since June 1985, 64 patients with follicular lymphoma have received cyclophosphamide (CY) 60 mg/kg x 2 and total-body irradiation (TBI) 2 Gy x 6 supported by ABMT as consolidation of second or subsequent remission. The marrow mononuclear cell (MNC) fraction was treated in vitro… CONTINUE READING